New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 17, 2014
10:12 EDTGNC, VSIGNC drops after analyst downgrades on sales concerns
Shares of vitamins and supplements retailer GNC (GNC) are falling after research firm Jefferies downgraded the stock to Hold from Buy in a note to investors today. WHAT'S NEW: The growth of vitamins and supplements sales appear to be slowing, as sales of the products were "flattish" in Q2 and rose only 1% through the four weeks ending July 5, wrote Jefferies analyst Mark Wiltamuth. Until recently, sales of the products had risen at a 6%-10% annual clip for years, the analyst reported. GNC will also face a hit following the FDA's crack down on a pre-workout supplement called DMAA, as the supplement accounted for 8% of the company's sales, Wiltamuth believes. Additionally, the company faces a tough comparison in Q2, as it launched its Gold Card discount plan in the second quarter of 2013, the analyst noted. Warning that GNC's comparative sales could drop in Q2 and Q3, Wiltamuth thinks anemic sales growth could hurt its margins. He slashed his price target on the name to $39 from $50. PRICE ACTION: In early trading, GNC shares fell 82c, or 2.3% to $34.78. One of GNC's competitors, Vitamin Shoppe (VSI), lost 0.7% to $42.72.
News For GNC;VSI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 21, 2014
09:12 EDTGNCGNC, eBay, Vivendi recommended as long ideas by Sandler, Bloomberg reports
Subscribe for More Information
October 20, 2014
14:46 EDTGNC, VSIVitamin Shoppe may hire adviser amid pressure for deal, Reuters says
Vitamin Shoppe (VSI), which has been urged by activist shareholders to consider a sale, is speaking to banks and may hire a financial adviser, according to Reuters, citing people familiar with the matter. Note that Reuters previously reported on September 18 that some large Vitamin Shoppe holders have urged the company to consider a sale to rival GNC Holdings (GNC) or to a private equity buyer. That same day, The Financial Times reported that GNC was considering a possible sale after receiving attention from private equity suitors. Following this latest report from Reuters, shares of Vitamin Shoppe are up 6.7% to $45.23 in afternoon trading, while GNC shares are up over 3% to $38.88. Reference Link
14:33 EDTVSIVitamin Shoppe up over 6%, near highs of session
14:21 EDTVSIVitamin Shoppe may appoint adviser as activist pressure continues, Reuters says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use